ArticleExpert opinion on investigational drugs2022

Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1.

Hue Tu Quach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.